Duke Health leadership launched Translating Duke Health in 2017 as a multi-disciplinary, multi-year commitment to capitalize on Dukes collective strengths in research, clinical care, and population health to address major health challenges.
This article is the fourth of a series exploring how Translating Duke Health has changed the health care landscape at Duke. Learn more about Translating Duke Health.
Translating Duke Health: Controlling the Immune System
Pause for a moment, and take a deep breath.
Now, as you read this, your immune system is hard at work: analyzing the thousands of microbes you just inhaled and which now fill your respiratory tract and lungs. Sensor cells, one of your bodys first lines of defense, are searching for potentially dangerous pathogens, and split decisions are made whether to trigger a defense response toward any unwelcome visitors.
When functioning properly, the immune system maintains this delicate balance on a continuous basis, scanning for friend or foe and responding accordingly. Understanding how the system functions harmoniously with our environment and how we can harness its power to improve human health is one of the five pillars of the Translating Duke Health Initiative.
Under the leadership of Allan D. Kirk, MD, PhD, chair of the Department of Surgery, the immunology steering committee has successfully worked for five years to increase funding for discovery-based and translational immunology research at Duke, recruiting top scientists in the field to the institution to continue this important work.
Every disease is influenced by immunity, Kirk said. The immune system has evolved over millions of years to maintain homeostasis despite continuous threat, and those threats can come from the outside, microorganisms, or trauma, but also from the inside when cells that are normal transform into cancer cells, or when the immune system inappropriately recognizes our own cells as being foreign, such as in autoimmune-disease.
Tapping into this powerful and complex system has the potential to improve human health in myriad ways.
In late 2019, as the world started to hear whispers of an emerging virus in China, Priyamvada Acharya, PhD, associate professor in the Departments of Surgery and Biochemistry, was in the process of applying for a grant on human parainfluenza virus type 3 (HPIV-3).
Acharya came to Duke in 2019 as a result of Translating Duke Healths recruitment efforts. As an immunologist who had studied the human immunodeficiency virus (HIV) for most of her professional career, Acharya was interested in using the tools she had already learned and apply them to a new virus.
The timing of this decision, it turns out, was serendipitous.
I started looking at the structure of the HPIV-3 fusion (F) protein, and was intrigued by its large central cavity, Acharya said. It was a structure that was unique, in that it was full of empty. We started looking at other viral proteins with similar large internal cavities, and came across the spike protein of coronaviruses. Thats when we turned our attention to SARS-CoV-2 that was emerging in China at the time.
Because Acharya was already funded by an R01 grant from the National Institutes of Health (NIH), she was able to receive a supplement to expand her work into studying coronaviruses and SARS-CoV-2. Previous efforts by the Translating Duke Health initiative to fund immunology research at Duke made this rapid pivot in research scope possible.
In a sense, we were taking our first steps, because we had no idea of the biology of this new virus, Acharya said, so we thought we should do what we know. We knew proteins, so if we forgot all the biology, that perspective would not be that hard.
Over the next year, Acharya and her collaborating researchers would study the protein structures on the surface of SARS-CoV-2, eventually discovering that the virus spike proteins were mutating to create variants that made the virus more transmissible. In August 2021, Acharya and her team published this important research in Science.
I want to thank the Translating Duke Health initiative, Acharya said. The startup funding I received was key to getting other funding and to really dig into new science. It was key to have that support from the Duke Human Vaccine Institute.
Acharya continues to study the new SARS-CoV-2 variants as they emerge, including BA.5, to understand how they are able to evade the bodys immune system even if antibodies are present from the COVID-19 vaccine.
Now, in 2022 as infections continue, the importance of this research is exceedingly clear.
While the immune system fights its continuous battle, researchers like Acharya study the invaders: the bacteria, viruses, and pathogens that cause disease.
Other scientists, such as R. Keith Reeves, PhD, professor in the Departments of Surgery and Pathology, focus their attention on the other side of the battlefield: investigating the biology of human cells and how they respond to these outside threats.
Reeves was recruited to Duke from Harvard University in 2021, joining the newly created Center for Human Systems Immunology, which was founded to promote Translating Duke Health efforts. His research, supported by multiple R01 and P01 grants from the NIH, seeks to answer questions about the mechanisms and behavior of natural killer (NK) cells.
Unlike T and B immune cells, which adapt over time as they encounter pathogens, NK cells are generally considered part of the bodys innate immune response, attacking anything in the body that appears to be non-self. Reeves has made notable strides in helping the scientific community understand the important role that NK cells play in the immune system.
It was thought for a long time that NK cells could not mount an adaptive response, that they can't adapt to individual antigens, said Reeves. But actually, we were one of the labs that first described that NK cells could actually have adaptive memory functions.
This discovery has opened the door for further investigation on how NK cells can be used in cell-based therapies, a major component of Reeves current research.
We are currently conducting molecular, cell-based, and protein assays to determine the mechanisms of how NK cells could best recognize an HIV-infected cell, or how they could recognize an influenza-infected cell, Reeves said. Then going one step beyond that, we want to know what mechanisms they use to eliminate them, once the NK cells recognize a sick cell versus a healthy one.
With gene-editing technologies such as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), Reeves says that NK cells could be modified and programmed to initiate a specific response. This process has the potential to create powerful cell-based immunotherapies.
Conversely, understanding the function of NK cells and how to suppress their immune response has other important applications, including in transplant research.
One of the reasons that our team came to Duke is that we are very interested in seeing where we could take our work and expertise and apply it to transplant studies, Reeves said. As good as NK cells can be for responding to infectious disease or cancer, they may actually complicate matters during organ transplant.
Reeves added that its important for research programs to study NK cells in reverse, learning how to dampen the immune response in order to achieve better outcomes.
Fortunately, Duke has a long history of investigative research in transplant immunology.
As a surgeon-scientist, fourth-year general surgery resident Brian Shaw, MD, has a unique perspective in the field of immunology. In the laboratory, he researches how immune cells specifically respond to organ transplant, how they change over time, and what treatments can be used to manipulate their response. In the operating room and clinic, he sees the direct impact of immunosuppressive therapies on patients post-transplant.
In spite of great advances in solid organ transplantation, we still have really poor outcomes for people with end-stage organ disease, Shaw said. In fact, successful kidney transplantation still only offers survival that is the same or worse as breast cancer with metastatic disease. Most of the morbidity and mortality associated with transplantation is due to imperfect immunosuppression.
Paraphrasing from Kirk, Shaw said that every immune response is a decision that has three components: specificity, context, and magnitude. Research has been able to successfully track the context in which the immune system activates and the magnitude of its response but the specificity of how the system works remains an unanswered question.
For patients who require immunosuppressive therapies, this gap in knowledge about the specific cells that respond to and injure a transplanted organ requires that the patients entire immune system be suppressed in order to prevent organ rejection.
As we know, immunosuppression is not benign, Shaw said. It has all sorts of negative side effects. Patients on chronic immunosuppression have two times the mortality rate from cancer as the general population.
As a potential solution, Shaws research tracks specific immune cells affected by transplant and how they can be manipulated to blunt their response to the new organ. Rather than lowering the overall level of activation of the immune system through immunosuppressive therapies, this research could reveal what therapies will specifically inhibit the cells which cause transplanted organs to fail.
Were fortunate to be at Duke, said Shaw, whose work is currently funded by an R38 grant to support clinician-scientists. This work requires very specialized instrumentation, and also specialized analysis. All the tools we're using utilize next-generation sequencing including single cell sequencing to analyze T cells and their specific receptors over time.
At Duke, an institution that recently completed its 10,000th organ transplant, Shaw says he is grateful to be in an environment that is able to help so many patients through transplant.
I think it shows you the impact that were having on people, Shaw said. Organ transplant is one of the few things that we do where the patients get better within a matter of days to weeks. Someone who needs a kidney transplant can sometimes be off dialysis the next day. If someone needs a liver transplant, they could be sick in an ICU on a ventilator, and within a week or two theyre walking out of the hospital to be with their families. It says something about our society, that weve been generous enough to donate these gifts to others.
Bettering outcomes for patients who receive improved immunotherapies, Shaw said, honors the gifts made by organ donors.
Acharya, Reeves, and Shaw are just three researchers among many at Duke who have been supported by the Translating Duke Health Initiative. Across the university, overlapping investigation contributes to our ability to unravel the mysteries of the immune system.
The understanding of how immunity can be harnessed as a tool to protect us better is the real focus of this initiative, Kirk said. The solution were seeking is to completely characterize and understand the signals used in that network so they can be harnessed, recognized, and mobilized as tools themselves.
With each scientific discovery, immunology researchers at Duke get closer to doing just that.
Scott Behm is Director of Communications for Duke Surgery
Visit link:
Unraveling the Mysteries of the Immune System - Duke University School of Medicine
- Overview of the Immune System - The Merck Manuals - March 18th, 2024
- What are the organs of the immune system? - InformedHealth.org - NCBI ... - January 17th, 2024
- Mom who homeschools her children reveals she lets her one-year-old play in and EAT mud - but insists it is goo - Daily Mail - November 26th, 2023
- The limits of nutritional supplements: they dont cure or prevent ailments, nor are they harmless - EL PAS USA - November 26th, 2023
- Here's how your gut affects your mental health, immune function and even cardiovascular health - indulgexpress - November 18th, 2023
- From fear to freedom: Anchor Paul LaGrone shares his story of sudden hair loss & the disease that caused it - ABC Action News Tampa Bay - May 9th, 2023
- Strengthen Your Immune System With 4 Simple Strategies - May 1st, 2023
- Immunodeficiency Awareness Month: What Is The Science Behind These Diseases? Know Warning Signs - ABP Live - May 1st, 2023
- Nearly 90% of patients with rare skin cancer respond to therapy that prevents tumors from evading the immune - cleveland.com - April 23rd, 2023
- University of Cincinnati researchers helping develop 'vaccine' to fight aggressive cancer - WKRC TV Cincinnati - April 23rd, 2023
- Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with... - April 23rd, 2023
- Immune System: Parts & Common Problems - Cleveland Clinic - March 21st, 2023
- Disorders of the Immune System | Johns Hopkins Medicine - March 21st, 2023
- Sometimes 15 Minutes Are More Than Enough To Improve Immune System, Sleep Quality And Depression - Revyuh - March 13th, 2023
- People produce endocannabinoids similar to compounds found in marijuana that are critical to many bodily functions - The Conversation Indonesia - February 24th, 2023
- Spending more time with your kids, grandkidsand their germsmay lower risk of a severe outcome from Covid-19, recent studies show - CNBC - December 20th, 2022
- Published in Journal for Immunotherapy of Cancer: Using Single-Cell Analysis to Assess the Effects of an Anti-OX40 Monoclonal Antibody in Its... - November 17th, 2022
- Man who had COVID-19 for 400 days finally cured after getting treated with antibodies, study says - msnNOW - November 17th, 2022
- Social Distancing: The Impact on Your Health and Immune System - Healthline - October 7th, 2022
- When Will ISR Immune System Regulation Holding AB (publ) (STO:ISR) Become Profitable? - Simply Wall St - October 7th, 2022
- VitaGaming Introduces Immune Support and Collagen to help Gamers boost immunity and fight stress - PR Web - October 7th, 2022
- Ohio reports third U.S. death of person with monkeypox who had underlying health conditions - CNBC - October 7th, 2022
- How a select few people have been cured of HIV - PBS - October 7th, 2022
- BeniCaros Wins Nutrition Industry Executive 2022 Immune Health Award - GlobeNewswire - October 7th, 2022
- Seasonal superfoods to give your immune system a boost this autumn - Yahoo Entertainment - October 7th, 2022
- Whats Going Around: Flu cases confirmed locally - ABC27 - October 7th, 2022
- Contributor: How to Fight the Cold and the Flu This Season - AJMC.com Managed Markets Network - October 7th, 2022
- Updated COVID-19 Bivalent Booster Released in Time for Fall and Winter Omicron Wave - Cornell University The Cornell Daily Sun - October 7th, 2022
- Oralair pill that retrains the immune system to reduce risk of thunderstorm asthma - 7NEWS - October 7th, 2022
- COVID immune reaction could affect brain mechanisms and induce neurological symptoms - Sky News - October 7th, 2022
- 7 Surprising Health Benefits of Pumpkins - AARP - October 7th, 2022
- Why Do Some Allergies Go Away While Others Dont? - The Atlantic - October 7th, 2022
- 15 foods to boost the immune system - Medical News Today - September 4th, 2022
- The powerful supplement that could enhance your immune response to bacteria and viruses - Express - September 4th, 2022
- New research: Cancer-fighting viruses can boost body's immune response - The Indian Express - September 4th, 2022
- Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it - The Conversation Indonesia - September 4th, 2022
- Study raises concerns about the effectiveness of the monkeypox vaccine - STAT - September 4th, 2022
- Five Natural Immune-Boosting Treatments to Try This Flu Season - Boston magazine - September 4th, 2022
- Returning to Football After COVID-19 Infection - Louisiana State University - September 4th, 2022
- #1 Best Way to Boost Your Immunity Against BA.5 Eat This Not That - Eat This, Not That - September 4th, 2022
- Whatever happened to the Botswana scientist who identified omicron then caught it? - NPR - September 4th, 2022
- Non-Hodgkin's lymphoma: What is the cancer that Jane Fonda announced she has? - FOX 29 Philadelphia - September 4th, 2022
- 8 Health Benefits of Cabbage - Health Essentials - September 4th, 2022
- Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features - BMC Women's... - September 4th, 2022
- VICTOR DAVIS HANSON: The mysteries of Long COVID - Las Vegas Review-Journal - September 4th, 2022
- Is This Popular Montana City The Most Depressed In The Nation? - XL Country - September 4th, 2022
- First adapted COVID-19 booster vaccines recommended for approval in the EU | European Medicines Agency - European Medicines Agency | - September 4th, 2022
- Potential of Vaccines in Treating Parkinson's, Alzheimer's Detailed | AC Immune to Launch Trial of Vaccine in Early-stage Parkinson's - Parkinson's... - September 4th, 2022
- What Are Zombie Cells? Here's How They Impact Aging - Prevention Magazine - September 4th, 2022
- What To Know About Hand, Foot and Mouth Disease - Health Essentials - September 4th, 2022
- On maternity and the stronger immune response in women - Nature.com - August 19th, 2022
- New study could change what we eat to supercharge immune system and fight disease - WOODTV.com - August 19th, 2022
- Extending dogs' lives, and sex and the immune system - MIT Technology Review - August 19th, 2022
- Your Immune System Will Thrive With This Elderberry Hill Liquid Morning Multivitamin - Men's Journal - August 19th, 2022
- Sure Signs Your Immune System Isn't as Strong as it Should Be Eat This Not That - Eat This, Not That - August 19th, 2022
- Can the monkeypox vaccine stop the current outbreak? : Goats and Soda - NPR - August 19th, 2022
- Getting A Grip On Influenza: The Pursuit Of A Universal Vaccine (Part 2) - Forbes - August 19th, 2022
- Bells Are Ringing! How Immunotherapy is Unlocking Doors to a Cancer Cure - Georgetowner - August 19th, 2022
- Have The Immune System Booster Through the Dietary Supplements Only from Berkeley Immune Support Formula - Digital Journal - August 19th, 2022
- COVID-19 and Flu Viruses Often Have a Deadly Accomplice: Bacterial Infections - Tufts Now - August 19th, 2022
- Eat This Fruit Daily to Stay Sharp and Live Longer, Research Find - The Beet - August 19th, 2022
- The Next COVID-19 Booster Shots Will Target Omicron: What to Know - Healthline - August 19th, 2022
- What to eat when you have COVID - Medical News Today - August 19th, 2022
- 3 Ways Good Inflammation Helps Your Body - First For Women - August 19th, 2022
- Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs | Scientific Reports -... - August 19th, 2022
- Nasal vaccines could snuff out COVID, but the hurdles are not to be sneezed at - Sydney Morning Herald - August 19th, 2022
- Paxlovid Rebound: RWE Analysis and Alternative Therapies in Development - BioSpace - August 19th, 2022
- Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment - Nature.com - August 19th, 2022
- What Happens When Your Immune System Gets Stressed Out? - Cleveland Clinic - July 8th, 2022
- Alcohol and the Immune System - PMC - PubMed Central (PMC) - July 8th, 2022
- Small NIH study reveals how immune response triggered by COVID-19 may damage the brain - National Institutes of Health (.gov) - July 8th, 2022
- Hyperactivation of the immune system may cause post-COVID syndromes - EurekAlert - July 8th, 2022
- Stress accelerates aging of the immune system - Open Access Government - July 8th, 2022
- Fight off Stress With Immune-Boosting Nutrients the right way - Longevity LIVE - July 8th, 2022
- Toxic chemical that can disrupt reproductive and immune system found in drinking water across country: Report - Times Now - July 8th, 2022
- COVID-19 and Osteoarthritis: Potential Connection and Outlook - Healthline - July 8th, 2022
- What is Your Gut Telling You? - Shepherd Express - July 8th, 2022
- How three kids got kidney transplants without immunosuppressants - Freethink - July 8th, 2022
- Coronavirus explainer: Can drinking green tea help with COVID symptoms? - Times of India - July 8th, 2022
- Immunization reduces the death rate in newborns - Times of India - July 8th, 2022